Institutional shares held 21.8 Million
203K calls
23.9K puts
Total value of holdings $134M
$1.25M calls
$146K puts
Market Cap $420M
68,350,896 Shares Out.
Institutional ownership 31.97%
# of Institutions 128


Latest Institutional Activity in CDXC

Top Purchases

Q1 2025
Silverberg Bernstein Capital Management LLC Shares Held: 95.5K ($587K)
Q1 2025
D.A. Davidson & Co. Shares Held: 11.8K ($72.1K)
Q1 2025
Rhumbline Advisers Shares Held: 67.4K ($414K)
Q1 2025
Resources Investment Advisors, Llc. Shares Held: 67.4K ($414K)
Q1 2025
Versant Capital Management, Inc Shares Held: 1.12K ($6.9K)

Top Sells

Q1 2025
Bsw Wealth Partners Shares Held: 81.8K ($503K)
Q1 2025
Sg Americas Securities, LLC Shares Held: 17.3K ($106K)
Q1 2025
Gamma Investing LLC Shares Held: 540 ($3.32K)
Q1 2025
Cornerstone Investment Partners, LLC Shares Held: 24.5K ($150K)
Q4 2024
Tieton Capital Management, LLC Shares Held: 2.59M ($15.9M)

About CDXC

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.


Insider Transactions at CDXC

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
11.6M Shares
From 6 Insiders
Open market or private purchase 11.4M shares
Exercise of conversion of derivative security 140K shares
Sell / Disposition
11.5M Shares
From 3 Insiders
Open market or private sale 11.5M shares

Track Institutional and Insider Activities on CDXC

Follow ChromaDex Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDXC shares.

Notify only if
Any

Insider Trading

Get notified when an Chroma Dex Corp. insider buys or sells CDXC shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to ChromaDex Corp.

Track Activities on CDXC